A share price of MBX Biosciences Inc [MBX] is currently trading at $32.55, up 13.41%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MBX shares have gain 5.34% over the last week, with a monthly amount glided 1.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on December 04, 2025, when Goldman initiated its Sell rating and assigned the stock a price target of $18. On October 15, 2025, Truist initiated with a Buy rating and assigned a price target of $50 on the stock. Mizuho initiated its recommendation with an Outperform and recommended $38 as its price target on August 05, 2025. Oppenheimer started tracking with an Outperform rating for this stock on July 16, 2025, and assigned it a price target of $38. In a note dated April 10, 2025, Citizens JMP initiated an Mkt Outperform rating and provided a target price of $38 on this stock.
MBX Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.81 and $35.55. Currently, Wall Street analysts expect the stock to reach $41.5 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $32.55 at the most recent close of the market. An investor can expect a potential return of 27.5% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Gross Profit Margin for this corporation currently stands at -0.3% with Operating Profit Margin at -409.32%, Pretax Profit Margin comes in at -362.59%, and Net Profit Margin reading is -362.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.29 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.92 points at the first support level, and at 27.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.79, and for the 2nd resistance point, it is at 37.03.
Ratios To Look Out For
To put it in perspective, the Current Ratio for MBX Biosciences Inc [NASDAQ:MBX] is 32.95. As well, the Quick Ratio is 32.95, while the Cash Ratio is 18.5.
Transactions by insiders
Recent insider trading involved Hawryluk P. Kent, President & CEO, that happened on Oct 20 ’25 when 20000.0 shares were purchased. Director, Hoerter Steven L. completed a deal on Oct 17 ’25 to buy 20000.0 shares. Meanwhile, Director Heron Patrick J bought 0.67 million shares on Sep 26 ’25.
